M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Lundbeck and Iambic partner to develop AI-driven migraine therapy
Danish pharmaceutical company H. Lundbeck A/S (CPH:HLUN-A) announced on Thursday that it has entered a strategic research collaboration with Iambic Therapeutics, a medical technology company, to discover a small molecule therapeutic for migraine treatment.
The agreement includes an upfront...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search